RHOFADE approved by the FDA

Good news to start 2017, and as predicted, the FDA has approved Allergan’s RHOFADE.

Yes they are going to use uppercase and scream RHOFADE at us everytime we see the product name.

Allergan says that RHOFADE will be available for commercial supply starting May 2017 in the United States.

Allergan Announces FDA Approval Of RHOFADE (Oxymetazoline Hydrochloride) Cream, 1% For The Topical Treatment Of Persistent Facial Erythema Associated With Rosacea In Adults

Once-Daily Treatment Reduces Persistent Facial Erythema (Redness) Associated With Rosacea Through 12 Hours

DUBLIN, Jan. 19, 2017 /PRNewswire/ — Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, announced today the approval of RHOFADE cream by the U.S. Food and Drug Administration (FDA) for the topical treatment of persistent facial erythema (redness) associated with rosacea in adults. Approval was based on two clinical studies that evaluated the primary efficacy endpoint on day 29.

“The FDA approval of RHOFADE™ exemplifies Allergan’s commitment to continuing to address unmet patient needs through innovation in medical dermatology,” said David Nicholson, Chief R&D Officer of Allergan plc. “We know persistent facial erythema associated with rosacea is a challenge for patients and physicians and having options can help in treating the disease. RHOFADE™ is the first and only alpha1A adrenoceptor agonist approved for persistent facial erythema associated with rosacea in adults. The FDA approval of RHOFADE™ represents a new prescription treatment that can effectively help physicians and their patients manage this condition.”

RHOFADE (oxymetazoline hydrochloride) cream, 1% is indicated for the topical treatment of persistent facial erythema associated with rosacea in adults.

Related Articles

 

About the Author

About the Author:

David Pascoe started the Rosacea Support Group in October 1998.

.

Follow Rosacea Support

Subscribe via RSS Feed Connect on Pinterest Connect on Google Plus

2 Reader Comments

  1. William Dafoe says:

    Do you know if it has been submitted for approval in Canada?

  2. Annie says:

    What about the rebound effect?

Leave a Comment

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.

%d bloggers like this: